Immunostimulatory colloidal delivery systems for cancer vaccines

Expert Opinion on Drug Delivery
Anne SaupeSarah Hook

Abstract

Cancer vaccine delivery is a multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies, such as colloidal immunostimulatory delivery systems. The importance of formulation strategies for cancer vaccines can be explained by the poor immunogenicity of tumour antigens. Colloidal vaccine delivery systems modify the kinetics, body distribution, uptake and release of the vaccine. This review explores recent research that is directed towards more targeted treatments of cancer through to colloidal vaccine delivery systems. Widely investigated carrier systems include polymeric micro- and nanoparticles, liposomes, archaeal lipid liposomes (archaeosomes), immune-stimulating complexes and virus-like particles. These systems are evaluated in terms of their formulation techniques, immunological mechanisms of action as well as the potential and limitations of such colloidal systems in the field of cancer vaccines.

References

Jan 1, 1995·Pharmaceutical Biotechnology·R K GuptaG R Siber
Sep 23, 1997·FEMS Microbiology Letters·G D SprottG B Patel
Aug 26, 1998·International Journal of Cancer. Journal International Du Cancer·A H van der VeenT L ten Hagen
Mar 14, 2000·Pharmaceutical Research·M L van SlootenR Kircheis
Jun 6, 2000·Advanced Drug Delivery Reviews·J C CoxI G Barr
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·F CottrezH Groux
Aug 23, 2001·Advanced Drug Delivery Reviews·L IllumS S Davis
Sep 22, 2001·Biomolecular Engineering·D T O'HaganM Singh
Aug 15, 2002·International Journal of Pharmaceutics·Tanima BanerjeeAmarnath Maitra
Jan 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shaobing ZhouHeming Li
Apr 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Niren MurthyJean M J Fréchet
Apr 23, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Petra LenzJohn T Schiller
Jan 6, 2004·Journal of Pharmaceutical Sciences·Manmohan SinghDerek T O'Hagan
Jan 13, 2004·Methods in Enzymology·G Dennis SprottLakshmi Krishnan
Feb 3, 2004·Immunology and Allergy Clinics of North America·Romain K Gherardi, François-Jérôme Authier
May 27, 2004·Vaccine·Aleksandra LenarczykAndreas Suhrbier
Jun 12, 2004·Advanced Drug Delivery Reviews·Bror MoreinIzzeldin Abusugra
Jun 16, 2004·International Journal of Pharmaceutics·Patrick H DemanaThomas Rades
Jul 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ian D DavisJonathan S Cebon
Aug 18, 2004·The Journal of Clinical Investigation·Alan N Houghton, José A Guevara-Patiño
Aug 19, 2004·Vaccine·Erik B Lindblad
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Sep 8, 2004·Advanced Drug Delivery Reviews·Lisa Brannon-Peppas, James O Blanchette

❮ Previous
Next ❯

Citations

Jun 12, 2009·Journal of Liposome Research·Sergio Madrigal-CarballoFrancisco Molina
Aug 23, 2011·Expert Review of Vaccines·Josianne Nitcheu Tefit, Vincent Serra
Jun 23, 2009·Expert Review of Vaccines·H Ciğdem ArcaSevda Senel
Dec 15, 2010·Expert Opinion on Drug Delivery·Najeh Maissar KhalilRubiana Mara Mainardes
Feb 11, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Akhilesh Kumar ShakyaHarvinder Singh Gill
Jun 18, 2011·Advanced Drug Delivery Reviews·Samar HamdyAfsaneh Lavasanifar
Dec 10, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Myrra G Carstens
Jul 1, 2008·Vaccine·Warren T McBurneySarah Hook
Mar 8, 2008·Advanced Drug Delivery Reviews·Laura J PeekCory Berkland
Mar 21, 2007·Proteomics·Vladimir BrusicEllis L Reinherz
Oct 1, 2014·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Deepa NarayananK P Chennazhi
Mar 24, 2016·International Immunology·Burcu TemizozKen J Ishii
Jun 28, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Viktoriya SokolovaMatthias Epple

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.